• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病和糖尿病患者的腹膜清除率:腹腔内异丙肾上腺素的作用

Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

作者信息

Nolph K D, Miller L, Husted F C, Hirszel P

出版信息

Int Urol Nephrol. 1976;8(2):161-9. doi: 10.1007/BF02082213.

DOI:10.1007/BF02082213
PMID:965210
Abstract

Reduced peritoneal clearances of creatinine and urate were demonstrated repeatedly in a patient with scleroderma and a patient with diabetes mellitus. Urea clearances were not significantly different from usual values. The findings suggest decreased peritoneal membrane permeability and/or area (if urea clearance is flow limited). Clearances increased to usual values with intraperitioneal isoproterenol in the patient with diabetes. There was no effect of isoproterenol in the patient with scleroderma.

摘要

在一名硬皮病患者和一名糖尿病患者中,反复证明肌酐和尿酸的腹膜清除率降低。尿素清除率与正常值无显著差异。这些发现提示腹膜通透性降低和/或面积减小(如果尿素清除率受流量限制)。在糖尿病患者中,腹膜内注射异丙肾上腺素后清除率升至正常值。在硬皮病患者中,异丙肾上腺素无此作用。

相似文献

1
Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.硬皮病和糖尿病患者的腹膜清除率:腹腔内异丙肾上腺素的作用
Int Urol Nephrol. 1976;8(2):161-9. doi: 10.1007/BF02082213.
2
Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.硬皮病患者腹膜清除率降低,腹腔注射异丙肾上腺素后清除率增加。
Ann Intern Med. 1973 Jun;78(6):891-4. doi: 10.7326/0003-4819-78-6-891.
3
Isoproterenol enhancement of peritoneal permeability.异丙肾上腺素增强腹膜通透性。
J Dial. 1977;1(4):319-31. doi: 10.3109/08860227709038423.
4
Transperitoneal solute movement in children.
Kidney Int Suppl. 1983 Nov;15:S95-100.
5
Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study.
Int Urol Nephrol. 1997;29(3):385-9. doi: 10.1007/BF02550940.
6
Peritoneal clearances. Long-term study.腹膜清除率。长期研究。
ASAIO Trans. 1988 Jul-Sep;34(3):437-40.
7
Peritoneal clearance of creatinine and inulin during dialysis in dogs: effect of splanchnic vasodilators.犬透析期间肌酐和菊粉的腹膜清除率:内脏血管扩张剂的作用
Kidney Int. 1979 Oct;16(4):459-69. doi: 10.1038/ki.1979.151.
8
Measurement of peritoneal clearances in self-dialysis patients.自我透析患者腹膜清除率的测量。
J Lab Clin Med. 1979 Oct;94(4):526-31.
9
Peritoneal dialysis in rabbits. A study of transperitoneal theophylline flux and peritoneal permeability.兔的腹膜透析。经腹膜的茶碱通量及腹膜通透性研究。
Nephron. 1978;20(1):18-23. doi: 10.1159/000181191.
10
Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
Kidney Int. 1979 Nov;16(5):619-23. doi: 10.1038/ki.1979.172.

本文引用的文献

1
On the direct nesslerization of ammonia formed by urease treatment of blood, serum, and urine.关于脲酶处理血液、血清和尿液所形成氨的直接奈斯勒化反应。
Am J Clin Pathol. 1958 Mar;29(3):277-80. doi: 10.1093/ajcp/29.3_ts.277.
2
A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method.一种改良的碳酸盐-磷钨酸盐法测定尿酸及其与分光光度尿酸酶法的比较。
Am J Clin Pathol. 1957 Aug;28(2):152-60. doi: 10.1093/ajcp/28.2.152.
3
The determination of creatinine in plasma or serum, and in urine; a critical examination.
血浆、血清及尿液中肌酐的测定:一项批判性研究。
Biochem J. 1954 Nov;58(3):426-37. doi: 10.1042/bj0580426.
4
The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.以过氧化物酶为示踪剂研究毛细血管通透性的超微结构基础。
J Cell Biol. 1967 Oct;35(1):213-36. doi: 10.1083/jcb.35.1.213.
5
Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat stress and exercise.热应激和运动相关急性肾衰竭中腹膜透析效率低下的机制。
Ann Intern Med. 1969 Aug;71(2):317-36. doi: 10.7326/0003-4819-71-2-317.
6
Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.使用高渗腹膜透析液后腹膜通透性的改变。
J Clin Invest. 1969 Jun;48(6):992-1001. doi: 10.1172/JCI106080.
7
Management of scleroderma.硬皮病的管理
Mayo Clin Proc. 1971 Feb;46(2):128-34.
8
Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.
Arch Intern Med. 1970 May;125(5):825-9. doi: 10.1001/archinte.125.5.825.
9
Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.利血平治疗雷诺病及雷诺现象。动脉内注射的短期反应。
Ann Intern Med. 1970 Jan;72(1):17-27. doi: 10.7326/0003-4819-72-1-17.
10
Altered peritoneal permeability in patients with systemic vasculitis.系统性血管炎患者腹膜通透性改变。
Ann Intern Med. 1971 Nov;75(5):753-5. doi: 10.7326/0003-4819-75-5-753.